RedHill Biopharma Ltd.
USPTO PatentsView assignee record - 40 granted patents across 3 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Redhill ranks #8,104 of 49,997 tracked US assignees by granted-patent volume, with 40 patents across 3 technology areas.
- #8,104
- of 49,997 US assignees by volume
- 37th percentile
- by Innovation Score (31.3/100)
- 14.7
- avg claims per patent
- +17%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R8104 · Foreign Corporation #8,104 · 40 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL
- GRANTS-SMALL 40 grants
- UPPER-Q #8,104/49,997
- PHOTO-FINISH Qnovo
- CPC-NARROW A61P · 3 areas
- INNOV-THIN 31.3/100
- CLAIMS-RICH 14.7 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-UP +17% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Qnovo Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Redhill’s 31.3 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Redhill
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Vivex Biomedical · near 31
Vivex Biomedical · near
31 score
- RedHill Biopharma · this assignee 31
RedHill Biopharma · this assignee
31 score
- T RAD · near 31
T RAD · near
31 score
- ConcealFab · near 31
ConcealFab · near
31 score
- Gorlan Team S L U · near 31
Gorlan Team S L U · near
31 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Redhill's Innovation Score is 31.3/100 (37th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Redhill?
Each dot is one of Redhill’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Redhill’s own 14.7 claims/patent is ABOVE the 10.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Redhill's grants concentrate
RedHill Biopharma Ltd. is a focused PatentsView assignee: 3 CPC subclasses with 97.5% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2021 (8 grants) versus a trough of 2 in 2016. By volume, Redhill sits between Qnovo Inc. and Spyderco, Inc..
Redhill's three-year grant acceleration
RedHill Biopharma Ltd. shows 9 grants in 2022–2024 against only 17 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at RedHill's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Qnovo
Qnovo Inc.
40 patents
- Quectel Wireless…
Quectel Wireless Solutions Co., Ltd.
40 patents
- RF DSP
RF DSP Inc
40 patents
- RPC Bramlage
RPC Bramlage GmbH
40 patents
- Resmed Motor
ResMed Motor Technologies Inc.
40 patents
- Sengled Optoelect…
Sengled Optoelectronics Co., Ltd.
40 patents
- Shenzhen Hello Te…
Shenzhen Hello Tech Energy Co., Ltd
40 patents
- Spyderco
Spyderco, Inc.
40 patents
- Redhill Biopharma ◀
RedHill Biopharma Ltd.
40 patents
What this shows RedHill holds 40 patents at rank #8,104, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near RedHill
By rank, the assignees closest to #8,104 in granted patent volume.
- Qnovo Inc. #8,100 · 40 patents
- Quectel Wireless Solutions Co., Ltd. #8,101 · 40 patents
- RF DSP Inc #8,102 · 40 patents
- RPC Bramlage GmbH #8,103 · 40 patents
- ResMed Motor Technologies Inc. #8,105 · 40 patents
- Sengled Optoelectronics Co., Ltd. #8,106 · 40 patents
- Shenzhen Hello Tech Energy Co., Ltd #8,107 · 40 patents
- Spyderco, Inc. #8,108 · 40 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in RedHill's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for RedHill, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), RedHill ranks #473 of 6,058 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (31 here).
Redhill's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
31 37th percentile higher than 37% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 7.5% |
| 2016 | 2 | 5.0% |
| 2017 | 4 | 10.0% |
| 2018 | 4 | 10.0% |
| 2019 | 5 | 12.5% |
| 2020 | 4 | 10.0% |
| 2021 | 8 | 20.0% |
| 2022 | 2 | 5.0% |
| 2023 | 3 | 7.5% |
| 2024 | 4 | 10.0% |
| 2025partial year | 1 | 2.5% |
Which technologies does RedHill Biopharma Ltd. patent most?
Top 3 of 3 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
RedHill Biopharma Ltd.'s patent record in context - here's where to go next.
- RedHill Biopharma Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 97.5% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #8,104 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare RedHill Biopharma Ltd. against Qnovo Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 31.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.